The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms

Area of Science:

• Breast pathology
• Oncology
• Molecular biology

Background:

• Mammary ductal hyperplasia encompasses benign breast lesions with varying malignant transformation risks.
• Atypia in hyperplasia correlates with increased potential for progression to ductal carcinoma in situ and invasive breast cancer.

Purpose of the Study:

• To review the factors contributing to the differential progression potential of mammary ductal hyperplasia.
• To synthesize insights into the epidemiologic, histopathologic, molecular, and environmental influences on hyperplasia progression.

Main Methods:

• Literature review of key studies from databases like PubMed.
• Focus on classification, risk stratification, genetic/epigenetic mechanisms, tumor microenvironment, and modifiable factors.

Main Results:

• Benign breast lesions are classified into non-proliferative, proliferative without atypia, and proliferative with atypia (e.g., atypical ductal hyperplasia).
• Atypia signifies a progression toward low-grade ductal carcinoma in situ, influenced by genetic alterations, epigenetic changes, and tumor microenvironment dynamics.
• Dietary factors (high-fat diet, obesity) and environmental toxins (endocrine disruptors, pesticides, radiation) exacerbate progression via inflammation, insulin resistance, genomic instability, and other mechanisms.

Conclusions:

• Stratified surveillance and biomarker-driven interventions are needed for high-risk hyperplasias.
• Lifestyle modifications and understanding molecular profiles are crucial for personalized prevention strategies.